Artificial Intelligence In Drug Repurposing Market Report 2026
Download Free Sample Buy Now
Artificial Intelligence In Drug Repurposing Market Report Infographic Image

Published : February 2026

Pages : 250

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Artificial Intelligence In Drug Repurposing Market Report 2026

Global Outlook – By Component (Software And Platforms, Services), By Technology (Machine Learning Or Deep Learning, Natural Language Processing (NLP), Knowledge Graphs And Network-Based Artificial Intelligence, Generative Artificial Intelligence And Large Language Models (LLMs), Computer Vision), By Deployment (Cloud-Based, On-Premises), By Therapeutic Area (Oncology, Neurology, Cardiovascular Diseases, Infectious Diseases, Immunology, Metabolic Disorders, Rare Diseases), By End-User (Pharmaceutical And Biotechnology Companies, Contract Research Organizations (CROs), Academic And Research Institutes, Healthcare Providers, Other End-Users) – Market Size, Trends, Strategies, and Forecast to 2035

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
Purchase This Report Download Sample PDF
Item added to cart!

Artificial Intelligence In Drug Repurposing Market Overview

• Artificial Intelligence In Drug Repurposing market size has reached to $1.05 billion in 2025

• Expected to grow to $2.63 billion in 2030 at a compound annual growth rate (CAGR) of 20.1%

• Growth Driver: Rising Demand For Precision Medicine Fueling The Growth Of The Market Due To Increasing Preference For Personalized And Targeted Therapies

• Market Trend: Accelerating Treatment Discovery Through Technology Integration

• North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Artificial Intelligence In Drug Repurposing Market?

Artificial intelligence in drug repurposing refers to the application of artificial intelligence techniques to identify new medical uses for existing drugs. It utilizes advanced data analytics, machine learning, and predictive modelling to analyse biological, chemical, and clinical data for potential therapeutic matches. This approach accelerates drug discovery, reduces research costs, and enhances the efficiency of pharmaceutical development.

The main components of artificial intelligence in drug repurposing include software and platforms and services. Software and platforms include digital tools and environments that enable the development, deployment, and use of applications and services. It uses various technologies such as machine learning or deep learning, natural language processing (NLP), knowledge graphs and network-based artificial intelligence, generative artificial intelligence and large language models (LLMs), and computer vision, and different deployment modes include cloud-based and on-premises. Various therapeutic areas include oncology, neurology, cardiovascular diseases, infectious diseases, immunology, metabolic disorders, and rare diseases and cater to several end-users, including pharmaceutical and biotechnology companies, contract research organizations (CROs), academic and research institutes, healthcare providers, and others.

Artificial Intelligence In Drug Repurposing market report bar graph

What Is The Artificial Intelligence In Drug Repurposing Market Size and Share 2026?

The artificial intelligence in drug repurposing market size has grown exponentially in recent years. It will grow from $1.05 billion in 2025 to $1.27 billion in 2026 at a compound annual growth rate (CAGR) of 20.3%. The growth in the historic period can be attributed to rising r&d costs in pharmaceutical development, availability of public biomedical datasets, growth of computational biology tools, need to accelerate time to market for therapies, increasing collaboration between pharma and AI startups.

What Is The Artificial Intelligence In Drug Repurposing Market Growth Forecast?

The artificial intelligence in drug repurposing market size is expected to see exponential growth in the next few years. It will grow to $2.63 billion in 2030 at a compound annual growth rate (CAGR) of 20.1%. The growth in the forecast period can be attributed to growth of AI-assisted clinical decision support, increasing use of generative AI for molecule insights, need for faster repurposing during health crises, expansion of real-world evidence analytics, rising investments in precision medicine pipelines. Major trends in the forecast period include AI-driven drug-target matching from multi-omics data, repurposing pipelines using knowledge graph discovery, virtual screening and trial simulation acceleration, federated learning for cross-institution research, explainable AI for clinical repurposing decisions.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us

Global Artificial Intelligence In Drug Repurposing Market Segmentation

1) By Component: Software And Platforms, Services

2) By Technology: Machine Learning Or Deep Learning, Natural Language Processing (NLP), Knowledge Graphs And Network-Based Artificial Intelligence, Generative Artificial Intelligence And Large Language Models (LLMs), Computer Vision

3) By Deployment: Cloud-Based, On-Premises

4) By Therapeutic Area: Oncology, Neurology, Cardiovascular Diseases, Infectious Diseases, Immunology, Metabolic Disorders, Rare Diseases

5) By End-User: Pharmaceutical And Biotechnology Companies, Contract Research Organizations (CROs), Academic And Research Institutes, Healthcare Providers, Other End-Users

Subsegments:

1) By Software And Platforms: Predictive Analytics Tools, Machine Learning Frameworks, Data Integration Systems, Drug Discovery Platforms, Clinical Trial Simulation Tools

2) By Services: Consulting Services, Data Management Services, Model Training And Optimization Services, Implementation And Integration Services, Support And Maintenance Services

What Is The Driver Of The Artificial Intelligence In Drug Repurposing Market?

The growing demand for precision medicine is expected to propel the growth of the artificial intelligence in drug repurposing market going forward. Precision medicine is a healthcare approach that customizes disease prevention and treatment based on an individual’s specific genes, behaviors, and environment. Rising demand for personalized treatments is driving the growth of precision medicine, as patients and healthcare providers increasingly seek therapies tailored to individual genetic and lifestyle profiles for improved effectiveness and reduced side effects. AI-driven drug repurposing enhances precision medicine by discovering existing drugs that align with an individual’s genetic or molecular characteristics, enabling more accurate and personalized treatment solutions. For instance, in February 2024, according to the Personalized Medicine Coalition, a US-based nonprofit organization, the FDA granted approval for 16 personalized therapies targeting rare diseases in 2023, a notable rise compared to the six approvals issued in 2022. Therefore, the growing demand for precision medicine is driving the growth of the artificial intelligence in drug repurposing industry.

Key Players In The Global Artificial Intelligence In Drug Repurposing Market

Major companies operating in the artificial intelligence in drug repurposing market are IBM Corporation, Evogene Ltd., Ginkgo Bioworks Holdings Inc., BioAge Labs Inc., Insilico Medicine Inc., BostonGene Corporation, ISOMORPHIC LABS, Recursion Pharmaceuticals Inc., Deep Genomics Inc., Healx Ltd., Owkin Inc., BullFrog AI Holdings Inc., Aicura Medical GmbH, Kantify, Ignota Labs Ltd., OrphAI Therapeutics, Nabla Bio, Atomwise Inc., BioXcel Therapeutics Inc., Graph AI.

Global Artificial Intelligence In Drug Repurposing Market Trends and Insights

Major companies operating in the artificial intelligence in drug repurposing market are focusing on the integration of advanced technologies in drug repositioning, such as computational drug repositioning systems, which systematically identify new therapeutic indications for existing drugs using data-driven analysis of literature and biological information. A computational drug repositioning system refers to a technology-driven platform that uses artificial intelligence, machine learning, and data mining to systematically analyze existing drugs, compounds, and biological data. For instance, in November 2023, Tempus, a US-based provider of AI-based precision medicine solutions, announced a multi-year strategic collaboration with Recursion, a US-based clinical stage biotechnology company, valued at up to $160 million over five years. The collaboration provides Recursion with access to Tempus’ extensive library of de-identified, multimodal oncology data to support biomarker-driven therapeutic development. By leveraging Tempus’ large-scale patient datasets alongside Recursion’s AI-enabled discovery capabilities, the partnership strengthens oncology drug repurposing initiatives, demonstrating how advanced computational platforms combined with real-world clinical data can accelerate the discovery of new treatment opportunities.

Need data on a specific region in this market?
Request Regional Data

What Are Latest Mergers And Acquisitions In The Artificial Intelligence In Drug Repurposing Market?

In January 2024, Cosmos Health Inc., a US-based diversified healthcare company, acquired Cloudscreen for an undisclosed amount. Through this acquisition, Cosmos Health aims to enhance drug repurposing capabilities and accelerate the identification of new therapeutic applications for existing drugs. Cloudscreen is a US-based company specializing in AI-powered drug repurposing solutions.

Regional Insights

North America was the largest region in the artificial intelligence in drug repurposing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Artificial Intelligence In Drug Repurposing Market?

The artificial intelligence in drug repurposing market includes revenues earned by entities by providing services such as predictive modelling, target identification, drug-disease interaction analysis, virtual screening, and clinical data mining. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Artificial Intelligence In Drug Repurposing Market Report 2026?

The artificial intelligence in drug repurposing market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the artificial intelligence in drug repurposing industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abdul Wasay

Artificial Intelligence In Drug Repurposing Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2026 $1.27 billion
Revenue Forecast In 2035 $2.63 billion
Growth Rate CAGR of 20.3% from 2026 to 2035
Base Year For Estimation 2025
Actual Estimates/Historical Data 2020-2025
Forecast Period 2026 - 2030 - 2035
Market Representation Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered Component, Technology, Deployment, Therapeutic Area, End-User
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled IBM Corporation, Evogene Ltd., Ginkgo Bioworks Holdings Inc., BioAge Labs Inc., Insilico Medicine Inc., BostonGene Corporation, ISOMORPHIC LABS, Recursion Pharmaceuticals Inc., Deep Genomics Inc., Healx Ltd., Owkin Inc., BullFrog AI Holdings Inc., Aicura Medical GmbH, Kantify, Ignota Labs Ltd., OrphAI Therapeutics, Nabla Bio, Atomwise Inc., BioXcel Therapeutics Inc., Graph AI.
Customization ScopeRequest for Customization
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Artificial Intelligence In Drug Repurposing Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Artificial Intelligence In Drug Repurposing Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Artificial Intelligence In Drug Repurposing Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Artificial Intelligence In Drug Repurposing Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Artificial Intelligence & Autonomous Intelligence

4.1.3 Digitalization, Cloud, Big Data & Cybersecurity

4.1.4 Fintech, Blockchain, Regtech & Digital Finance

4.1.5 Sustainability, Climate Tech & Circular Economy

4.2. Major Trends

4.2.1 AI-Driven Drug-Target Matching From Multi-Omics Data

4.2.2 Repurposing Pipelines Using Knowledge Graph Discovery

4.2.3 Virtual Screening And Trial Simulation Acceleration

4.2.4 Federated Learning For Cross-Institution Research

4.2.5 Explainable AI For Clinical Repurposing Decisions

5. Artificial Intelligence In Drug Repurposing Market Analysis Of End Use Industries

5.1 Pharmaceutical And Biotechnology Companies

5.2 Contract Research Organizations (Cros)

5.3 Academic And Research Institutes

5.4 Healthcare Providers

5.5 Government Research Agencies

6. Artificial Intelligence In Drug Repurposing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Artificial Intelligence In Drug Repurposing Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Artificial Intelligence In Drug Repurposing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Artificial Intelligence In Drug Repurposing Market Size, Comparisons And Growth Rate Analysis

7.3. Global Artificial Intelligence In Drug Repurposing Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Artificial Intelligence In Drug Repurposing Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Artificial Intelligence In Drug Repurposing Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Artificial Intelligence In Drug Repurposing Market Segmentation

9.1. Global Artificial Intelligence In Drug Repurposing Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Software And Platforms, Services

9.2. Global Artificial Intelligence In Drug Repurposing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Machine Learning Or Deep Learning, Natural Language Processing (NLP), Knowledge Graphs And Network-Based Artificial Intelligence, Generative Artificial Intelligence And Large Language Models (LLMs), Computer Vision

9.3. Global Artificial Intelligence In Drug Repurposing Market, Segmentation By Deployment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Cloud-Based, On-Premises

9.4. Global Artificial Intelligence In Drug Repurposing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Oncology, Neurology, Cardiovascular Diseases, Infectious Diseases, Immunology, Metabolic Disorders, Rare Diseases

9.5. Global Artificial Intelligence In Drug Repurposing Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Pharmaceutical And Biotechnology Companies, Contract Research Organizations (CROs), Academic And Research Institutes, Healthcare Providers, Other End-Users

9.6. Global Artificial Intelligence In Drug Repurposing Market, Sub-Segmentation Of Software And Platforms, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Predictive Analytics Tools, Machine Learning Frameworks, Data Integration Systems, Drug Discovery Platforms, Clinical Trial Simulation Tools

9.7. Global Artificial Intelligence In Drug Repurposing Market, Sub-Segmentation Of Services, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Consulting Services, Data Management Services, Model Training And Optimization Services, Implementation And Integration Services, Support And Maintenance Services

10. Artificial Intelligence In Drug Repurposing Market, Industry Metrics By Country

10.1. Global Artificial Intelligence In Drug Repurposing Market, Average Selling Price By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $

10.2. Global Artificial Intelligence In Drug Repurposing Market, Average Spending Per Capita (Employed) By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $

11. Artificial Intelligence In Drug Repurposing Market Regional And Country Analysis

11.1. Global Artificial Intelligence In Drug Repurposing Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11.2. Global Artificial Intelligence In Drug Repurposing Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. Asia-Pacific Artificial Intelligence In Drug Repurposing Market

12.1. Asia-Pacific Artificial Intelligence In Drug Repurposing Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. Asia-Pacific Artificial Intelligence In Drug Repurposing Market, Segmentation By Component, Segmentation By Technology, Segmentation By Deployment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. China Artificial Intelligence In Drug Repurposing Market

13.1. China Artificial Intelligence In Drug Repurposing Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

13.2. China Artificial Intelligence In Drug Repurposing Market, Segmentation By Component, Segmentation By Technology, Segmentation By Deployment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. India Artificial Intelligence In Drug Repurposing Market

14.1. India Artificial Intelligence In Drug Repurposing Market, Segmentation By Component, Segmentation By Technology, Segmentation By Deployment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Japan Artificial Intelligence In Drug Repurposing Market

15.1. Japan Artificial Intelligence In Drug Repurposing Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

15.2. Japan Artificial Intelligence In Drug Repurposing Market, Segmentation By Component, Segmentation By Technology, Segmentation By Deployment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Australia Artificial Intelligence In Drug Repurposing Market

16.1. Australia Artificial Intelligence In Drug Repurposing Market, Segmentation By Component, Segmentation By Technology, Segmentation By Deployment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. Indonesia Artificial Intelligence In Drug Repurposing Market

17.1. Indonesia Artificial Intelligence In Drug Repurposing Market, Segmentation By Component, Segmentation By Technology, Segmentation By Deployment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. South Korea Artificial Intelligence In Drug Repurposing Market

18.1. South Korea Artificial Intelligence In Drug Repurposing Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

18.2. South Korea Artificial Intelligence In Drug Repurposing Market, Segmentation By Component, Segmentation By Technology, Segmentation By Deployment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. Taiwan Artificial Intelligence In Drug Repurposing Market

19.1. Taiwan Artificial Intelligence In Drug Repurposing Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

19.2. Taiwan Artificial Intelligence In Drug Repurposing Market, Segmentation By Component, Segmentation By Technology, Segmentation By Deployment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. South East Asia Artificial Intelligence In Drug Repurposing Market

20.1. South East Asia Artificial Intelligence In Drug Repurposing Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

20.2. South East Asia Artificial Intelligence In Drug Repurposing Market, Segmentation By Component, Segmentation By Technology, Segmentation By Deployment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. Western Europe Artificial Intelligence In Drug Repurposing Market

21.1. Western Europe Artificial Intelligence In Drug Repurposing Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

21.2. Western Europe Artificial Intelligence In Drug Repurposing Market, Segmentation By Component, Segmentation By Technology, Segmentation By Deployment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. UK Artificial Intelligence In Drug Repurposing Market

22.1. UK Artificial Intelligence In Drug Repurposing Market, Segmentation By Component, Segmentation By Technology, Segmentation By Deployment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. Germany Artificial Intelligence In Drug Repurposing Market

23.1. Germany Artificial Intelligence In Drug Repurposing Market, Segmentation By Component, Segmentation By Technology, Segmentation By Deployment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. France Artificial Intelligence In Drug Repurposing Market

24.1. France Artificial Intelligence In Drug Repurposing Market, Segmentation By Component, Segmentation By Technology, Segmentation By Deployment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Italy Artificial Intelligence In Drug Repurposing Market

25.1. Italy Artificial Intelligence In Drug Repurposing Market, Segmentation By Component, Segmentation By Technology, Segmentation By Deployment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Spain Artificial Intelligence In Drug Repurposing Market

26.1. Spain Artificial Intelligence In Drug Repurposing Market, Segmentation By Component, Segmentation By Technology, Segmentation By Deployment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Eastern Europe Artificial Intelligence In Drug Repurposing Market

27.1. Eastern Europe Artificial Intelligence In Drug Repurposing Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

27.2. Eastern Europe Artificial Intelligence In Drug Repurposing Market, Segmentation By Component, Segmentation By Technology, Segmentation By Deployment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. Russia Artificial Intelligence In Drug Repurposing Market

28.1. Russia Artificial Intelligence In Drug Repurposing Market, Segmentation By Component, Segmentation By Technology, Segmentation By Deployment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. North America Artificial Intelligence In Drug Repurposing Market

29.1. North America Artificial Intelligence In Drug Repurposing Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

29.2. North America Artificial Intelligence In Drug Repurposing Market, Segmentation By Component, Segmentation By Technology, Segmentation By Deployment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. USA Artificial Intelligence In Drug Repurposing Market

30.1. USA Artificial Intelligence In Drug Repurposing Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

30.2. USA Artificial Intelligence In Drug Repurposing Market, Segmentation By Component, Segmentation By Technology, Segmentation By Deployment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. Canada Artificial Intelligence In Drug Repurposing Market

31.1. Canada Artificial Intelligence In Drug Repurposing Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

31.2. Canada Artificial Intelligence In Drug Repurposing Market, Segmentation By Component, Segmentation By Technology, Segmentation By Deployment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. South America Artificial Intelligence In Drug Repurposing Market

32.1. South America Artificial Intelligence In Drug Repurposing Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

32.2. South America Artificial Intelligence In Drug Repurposing Market, Segmentation By Component, Segmentation By Technology, Segmentation By Deployment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Brazil Artificial Intelligence In Drug Repurposing Market

33.1. Brazil Artificial Intelligence In Drug Repurposing Market, Segmentation By Component, Segmentation By Technology, Segmentation By Deployment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Middle East Artificial Intelligence In Drug Repurposing Market

34.1. Middle East Artificial Intelligence In Drug Repurposing Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

34.2. Middle East Artificial Intelligence In Drug Repurposing Market, Segmentation By Component, Segmentation By Technology, Segmentation By Deployment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Africa Artificial Intelligence In Drug Repurposing Market

35.1. Africa Artificial Intelligence In Drug Repurposing Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

35.2. Africa Artificial Intelligence In Drug Repurposing Market, Segmentation By Component, Segmentation By Technology, Segmentation By Deployment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

36. Artificial Intelligence In Drug Repurposing Market Regulatory and Investment Landscape

37. Artificial Intelligence In Drug Repurposing Market Competitive Landscape And Company Profiles

37.1. Artificial Intelligence In Drug Repurposing Market Competitive Landscape And Market Share 2024

37.1.1. Top 10 Companies (Ranked by revenue/share)

37.2. Artificial Intelligence In Drug Repurposing Market - Company Scoring Matrix

37.2.1. Market Revenues

37.2.2. Product Innovation Score

37.2.3. Brand Recognition

37.3. Artificial Intelligence In Drug Repurposing Market Company Profiles

37.3.1. IBM Corporation Overview, Products and Services, Strategy and Financial Analysis

37.3.2. Evogene Ltd. Overview, Products and Services, Strategy and Financial Analysis

37.3.3. Ginkgo Bioworks Holdings Inc. Overview, Products and Services, Strategy and Financial Analysis

37.3.4. BioAge Labs Inc. Overview, Products and Services, Strategy and Financial Analysis

37.3.5. Insilico Medicine Inc. Overview, Products and Services, Strategy and Financial Analysis

38. Artificial Intelligence In Drug Repurposing Market Other Major And Innovative Companies

BostonGene Corporation, ISOMORPHIC LABS, Recursion Pharmaceuticals Inc., Deep Genomics Inc., Healx Ltd., Owkin Inc., BullFrog AI Holdings Inc., Aicura Medical GmbH, Kantify, Ignota Labs Ltd., OrphAI Therapeutics, Nabla Bio, Atomwise Inc., BioXcel Therapeutics Inc., Graph AI

39. Global Artificial Intelligence In Drug Repurposing Market Competitive Benchmarking And Dashboard

40. Key Mergers And Acquisitions In The Artificial Intelligence In Drug Repurposing Market

41. Artificial Intelligence In Drug Repurposing Market High Potential Countries, Segments and Strategies

41.1. Artificial Intelligence In Drug Repurposing Market In 2030 - Countries Offering Most New Opportunities

41.2. Artificial Intelligence In Drug Repurposing Market In 2030 - Segments Offering Most New Opportunities

41.3. Artificial Intelligence In Drug Repurposing Market In 2030 - Growth Strategies

41.3.1. Market Trend Based Strategies

41.3.2. Competitor Strategies

42. Appendix

42.1. Abbreviations

42.2. Currencies

42.3. Historic And Forecast Inflation Rates

42.4. Research Inquiries

42.5. The Business Research Company

42.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Artificial Intelligence In Drug Repurposing Market, Overview Of Key Products - Product Examples
  • Table 2: Global Artificial Intelligence In Drug Repurposing Market Attractiveness, Factor-Wise Evaluation
  • Table 3: Global Artificial Intelligence In Drug Repurposing Market, Supply Chain Analysis
  • Table 4: Global Artificial Intelligence In Drug Repurposing Market, Major Raw Material Providers
  • Table 5: Global Artificial Intelligence In Drug Repurposing Market, Major Resource Providers
  • Table 6: Global Artificial Intelligence In Drug Repurposing Market, Major Manufacturers (Suppliers)
  • Table 7: Global Artificial Intelligence In Drug Repurposing Market, Major Distributors And Channel Partners
  • Table 8: Global Artificial Intelligence In Drug Repurposing Market, Key Technologies & Future Trends
  • Table 9: Global Artificial Intelligence In Drug Repurposing Market, Major Trends
  • Table 10: Global Artificial Intelligence In Drug Repurposing Market, Major End Users
  • Table 11: Global Artificial Intelligence In Drug Repurposing Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Table 12: Global Artificial Intelligence In Drug Repurposing Historic Market Growth, 2020-2025, $ Billion
  • Table 13: Global Artificial Intelligence In Drug Repurposing Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Table 14: Global Artificial Intelligence In Drug Repurposing Market - TAM, US$ Billion, 2025
  • Table 15: Global Artificial Intelligence In Drug Repurposing Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 16: Global Artificial Intelligence In Drug Repurposing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 17: Global Artificial Intelligence In Drug Repurposing Market, Segmentation By Deployment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 18: Global Artificial Intelligence In Drug Repurposing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 19: Global Artificial Intelligence In Drug Repurposing Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 20: Global Artificial Intelligence In Drug Repurposing Market, Sub-Segmentation Of Software And Platforms, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 21: Global Artificial Intelligence In Drug Repurposing Market, Sub-Segmentation Of Services, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 22: Global Artificial Intelligence In Drug Repurposing Market, Average Selling Price By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $
  • Table 23: Global Artificial Intelligence In Drug Repurposing Market, Average Spending Per Capita (Employed) By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $
  • Table 24: Global Artificial Intelligence In Drug Repurposing Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 25: Global Artificial Intelligence In Drug Repurposing Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 26: Asia-Pacific, Artificial Intelligence In Drug Repurposing Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 27: Asia-Pacific, Artificial Intelligence In Drug Repurposing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 28: Asia-Pacific, Artificial Intelligence In Drug Repurposing Market, Segmentation By Deployment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 29: China, Artificial Intelligence In Drug Repurposing Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 30: China, Artificial Intelligence In Drug Repurposing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 31: China, Artificial Intelligence In Drug Repurposing Market, Segmentation By Deployment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 32: India, Artificial Intelligence In Drug Repurposing Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 33: India, Artificial Intelligence In Drug Repurposing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 34: India, Artificial Intelligence In Drug Repurposing Market, Segmentation By Deployment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 35: Japan, Artificial Intelligence In Drug Repurposing Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 36: Japan, Artificial Intelligence In Drug Repurposing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 37: Japan, Artificial Intelligence In Drug Repurposing Market, Segmentation By Deployment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 38: Australia, Artificial Intelligence In Drug Repurposing Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 39: Australia, Artificial Intelligence In Drug Repurposing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 40: Australia, Artificial Intelligence In Drug Repurposing Market, Segmentation By Deployment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 41: Indonesia, Artificial Intelligence In Drug Repurposing Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 42: Indonesia, Artificial Intelligence In Drug Repurposing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 43: Indonesia, Artificial Intelligence In Drug Repurposing Market, Segmentation By Deployment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 44: South Korea, Artificial Intelligence In Drug Repurposing Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 45: South Korea, Artificial Intelligence In Drug Repurposing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 46: South Korea, Artificial Intelligence In Drug Repurposing Market, Segmentation By Deployment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 47: Taiwan, Artificial Intelligence In Drug Repurposing Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 48: Taiwan, Artificial Intelligence In Drug Repurposing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 49: Taiwan, Artificial Intelligence In Drug Repurposing Market, Segmentation By Deployment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 50: South East Asia, Artificial Intelligence In Drug Repurposing Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 51: South East Asia, Artificial Intelligence In Drug Repurposing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 52: South East Asia, Artificial Intelligence In Drug Repurposing Market, Segmentation By Deployment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 53: Western Europe, Artificial Intelligence In Drug Repurposing Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 54: Western Europe, Artificial Intelligence In Drug Repurposing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 55: Western Europe, Artificial Intelligence In Drug Repurposing Market, Segmentation By Deployment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 56: UK, Artificial Intelligence In Drug Repurposing Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 57: UK, Artificial Intelligence In Drug Repurposing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 58: UK, Artificial Intelligence In Drug Repurposing Market, Segmentation By Deployment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 59: Germany, Artificial Intelligence In Drug Repurposing Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 60: Germany, Artificial Intelligence In Drug Repurposing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 61: Germany, Artificial Intelligence In Drug Repurposing Market, Segmentation By Deployment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 62: France, Artificial Intelligence In Drug Repurposing Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 63: France, Artificial Intelligence In Drug Repurposing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 64: France, Artificial Intelligence In Drug Repurposing Market, Segmentation By Deployment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 65: Italy, Artificial Intelligence In Drug Repurposing Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 66: Italy, Artificial Intelligence In Drug Repurposing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 67: Italy, Artificial Intelligence In Drug Repurposing Market, Segmentation By Deployment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 68: Spain, Artificial Intelligence In Drug Repurposing Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 69: Spain, Artificial Intelligence In Drug Repurposing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 70: Spain, Artificial Intelligence In Drug Repurposing Market, Segmentation By Deployment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 71: Eastern Europe, Artificial Intelligence In Drug Repurposing Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 72: Eastern Europe, Artificial Intelligence In Drug Repurposing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 73: Eastern Europe, Artificial Intelligence In Drug Repurposing Market, Segmentation By Deployment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 74: Russia, Artificial Intelligence In Drug Repurposing Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 75: Russia, Artificial Intelligence In Drug Repurposing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 76: Russia, Artificial Intelligence In Drug Repurposing Market, Segmentation By Deployment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 77: North America, Artificial Intelligence In Drug Repurposing Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 78: North America, Artificial Intelligence In Drug Repurposing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 79: North America, Artificial Intelligence In Drug Repurposing Market, Segmentation By Deployment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 80: USA, Artificial Intelligence In Drug Repurposing Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 81: USA, Artificial Intelligence In Drug Repurposing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 82: USA, Artificial Intelligence In Drug Repurposing Market, Segmentation By Deployment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 83: Canada, Artificial Intelligence In Drug Repurposing Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 84: Canada, Artificial Intelligence In Drug Repurposing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 85: Canada, Artificial Intelligence In Drug Repurposing Market, Segmentation By Deployment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 86: South America, Artificial Intelligence In Drug Repurposing Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 87: South America, Artificial Intelligence In Drug Repurposing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 88: South America, Artificial Intelligence In Drug Repurposing Market, Segmentation By Deployment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 89: Brazil, Artificial Intelligence In Drug Repurposing Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 90: Brazil, Artificial Intelligence In Drug Repurposing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 91: Brazil, Artificial Intelligence In Drug Repurposing Market, Segmentation By Deployment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 92: Middle East, Artificial Intelligence In Drug Repurposing Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 93: Middle East, Artificial Intelligence In Drug Repurposing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 94: Middle East, Artificial Intelligence In Drug Repurposing Market, Segmentation By Deployment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 95: Africa, Artificial Intelligence In Drug Repurposing Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 96: Africa, Artificial Intelligence In Drug Repurposing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 97: Africa, Artificial Intelligence In Drug Repurposing Market, Segmentation By Deployment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 98: Global Artificial Intelligence In Drug Repurposing Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Table 99: Global Artificial Intelligence In Drug Repurposing Market - Company Scoring Matrix
  • Table 100: IBM Corporation Financial Performance
  • Table 101: Evogene Ltd. Financial Performance
  • Table 102: Ginkgo Bioworks Holdings Inc. Financial Performance
  • Table 103: BioAge Labs Inc. Financial Performance
  • Table 104: Insilico Medicine Inc. Financial Performance
  • Table 105: Global Artificial Intelligence In Drug Repurposing Market, Competitive Benchmarking (In USD Billions)
  • Table 106: Global Artificial Intelligence In Drug Repurposing Market, Competitive Dashboard
  • Table 107: Global Artificial Intelligence In Drug Repurposing Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Table 108: Global, Artificial Intelligence In Drug Repurposing Market Size Gain ($ Billion), Segmentation By Component, 2025 – 2030
  • Table 109: Global, Artificial Intelligence In Drug Repurposing Market Size Gain ($ Billion), Segmentation By Technology, 2025 – 2030
  • Table 110: Global, Artificial Intelligence In Drug Repurposing Market Size Gain ($ Billion), Segmentation By Deployment, 2025 – 2030

List Of Figures

    Figure 1: Global Artificial Intelligence In Drug Repurposing Market, Overview Of Key Products - Product Examples
  • Figure 2: Global Artificial Intelligence In Drug Repurposing Market Attractiveness, Factor-Wise Evaluation
  • Figure 3: Global Artificial Intelligence In Drug Repurposing Market, Supply Chain Analysis
  • Figure 4: Global Artificial Intelligence In Drug Repurposing Market, Major Raw Material Providers
  • Figure 5: Global Artificial Intelligence In Drug Repurposing Market, Major Resource Providers
  • Figure 6: Global Artificial Intelligence In Drug Repurposing Market, Major Manufacturers (Suppliers)
  • Figure 7: Global Artificial Intelligence In Drug Repurposing Market, Major Distributors And Channel Partners
  • Figure 8: Global Artificial Intelligence In Drug Repurposing Market, Key Technologies & Future Trends
  • Figure 9: Global Artificial Intelligence In Drug Repurposing Market, Major Trends
  • Figure 10: Global Artificial Intelligence In Drug Repurposing Market, Major End Users
  • Figure 11: Global Artificial Intelligence In Drug Repurposing Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Figure 12: Global Artificial Intelligence In Drug Repurposing Historic Market Growth, 2020-2025, $ Billion
  • Figure 13: Global Artificial Intelligence In Drug Repurposing Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Figure 14: Global Artificial Intelligence In Drug Repurposing Market - TAM, US$ Billion, 2025
  • Figure 15: Global Artificial Intelligence In Drug Repurposing Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 16: Global Artificial Intelligence In Drug Repurposing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 17: Global Artificial Intelligence In Drug Repurposing Market, Segmentation By Deployment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 18: Global Artificial Intelligence In Drug Repurposing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 19: Global Artificial Intelligence In Drug Repurposing Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 20: Global Artificial Intelligence In Drug Repurposing Market, Sub-Segmentation Of Software And Platforms, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 21: Global Artificial Intelligence In Drug Repurposing Market, Sub-Segmentation Of Services, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 22: Global Artificial Intelligence In Drug Repurposing Market, Average Selling Price By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $
  • Figure 23: Global Artificial Intelligence In Drug Repurposing Market, Average Spending Per Capita (Employed) By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $
  • Figure 24: Global Artificial Intelligence In Drug Repurposing Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 25: Global Artificial Intelligence In Drug Repurposing Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 26: Asia-Pacific, Artificial Intelligence In Drug Repurposing Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 27: Asia-Pacific, Artificial Intelligence In Drug Repurposing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 28: Asia-Pacific, Artificial Intelligence In Drug Repurposing Market, Segmentation By Deployment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 29: China, Artificial Intelligence In Drug Repurposing Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 30: China, Artificial Intelligence In Drug Repurposing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 31: China, Artificial Intelligence In Drug Repurposing Market, Segmentation By Deployment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 32: India, Artificial Intelligence In Drug Repurposing Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 33: India, Artificial Intelligence In Drug Repurposing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 34: India, Artificial Intelligence In Drug Repurposing Market, Segmentation By Deployment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 35: Japan, Artificial Intelligence In Drug Repurposing Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 36: Japan, Artificial Intelligence In Drug Repurposing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 37: Japan, Artificial Intelligence In Drug Repurposing Market, Segmentation By Deployment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 38: Australia, Artificial Intelligence In Drug Repurposing Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 39: Australia, Artificial Intelligence In Drug Repurposing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 40: Australia, Artificial Intelligence In Drug Repurposing Market, Segmentation By Deployment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 41: Indonesia, Artificial Intelligence In Drug Repurposing Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 42: Indonesia, Artificial Intelligence In Drug Repurposing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 43: Indonesia, Artificial Intelligence In Drug Repurposing Market, Segmentation By Deployment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 44: South Korea, Artificial Intelligence In Drug Repurposing Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 45: South Korea, Artificial Intelligence In Drug Repurposing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 46: South Korea, Artificial Intelligence In Drug Repurposing Market, Segmentation By Deployment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 47: Taiwan, Artificial Intelligence In Drug Repurposing Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 48: Taiwan, Artificial Intelligence In Drug Repurposing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 49: Taiwan, Artificial Intelligence In Drug Repurposing Market, Segmentation By Deployment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 50: South East Asia, Artificial Intelligence In Drug Repurposing Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 51: South East Asia, Artificial Intelligence In Drug Repurposing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 52: South East Asia, Artificial Intelligence In Drug Repurposing Market, Segmentation By Deployment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 53: Western Europe, Artificial Intelligence In Drug Repurposing Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 54: Western Europe, Artificial Intelligence In Drug Repurposing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 55: Western Europe, Artificial Intelligence In Drug Repurposing Market, Segmentation By Deployment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 56: UK, Artificial Intelligence In Drug Repurposing Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 57: UK, Artificial Intelligence In Drug Repurposing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 58: UK, Artificial Intelligence In Drug Repurposing Market, Segmentation By Deployment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 59: Germany, Artificial Intelligence In Drug Repurposing Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 60: Germany, Artificial Intelligence In Drug Repurposing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 61: Germany, Artificial Intelligence In Drug Repurposing Market, Segmentation By Deployment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 62: France, Artificial Intelligence In Drug Repurposing Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 63: France, Artificial Intelligence In Drug Repurposing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 64: France, Artificial Intelligence In Drug Repurposing Market, Segmentation By Deployment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 65: Italy, Artificial Intelligence In Drug Repurposing Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 66: Italy, Artificial Intelligence In Drug Repurposing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 67: Italy, Artificial Intelligence In Drug Repurposing Market, Segmentation By Deployment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 68: Spain, Artificial Intelligence In Drug Repurposing Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 69: Spain, Artificial Intelligence In Drug Repurposing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 70: Spain, Artificial Intelligence In Drug Repurposing Market, Segmentation By Deployment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 71: Eastern Europe, Artificial Intelligence In Drug Repurposing Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 72: Eastern Europe, Artificial Intelligence In Drug Repurposing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 73: Eastern Europe, Artificial Intelligence In Drug Repurposing Market, Segmentation By Deployment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 74: Russia, Artificial Intelligence In Drug Repurposing Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 75: Russia, Artificial Intelligence In Drug Repurposing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 76: Russia, Artificial Intelligence In Drug Repurposing Market, Segmentation By Deployment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 77: North America, Artificial Intelligence In Drug Repurposing Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 78: North America, Artificial Intelligence In Drug Repurposing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 79: North America, Artificial Intelligence In Drug Repurposing Market, Segmentation By Deployment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 80: USA, Artificial Intelligence In Drug Repurposing Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 81: USA, Artificial Intelligence In Drug Repurposing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 82: USA, Artificial Intelligence In Drug Repurposing Market, Segmentation By Deployment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 83: Canada, Artificial Intelligence In Drug Repurposing Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 84: Canada, Artificial Intelligence In Drug Repurposing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 85: Canada, Artificial Intelligence In Drug Repurposing Market, Segmentation By Deployment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 86: South America, Artificial Intelligence In Drug Repurposing Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 87: South America, Artificial Intelligence In Drug Repurposing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 88: South America, Artificial Intelligence In Drug Repurposing Market, Segmentation By Deployment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 89: Brazil, Artificial Intelligence In Drug Repurposing Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 90: Brazil, Artificial Intelligence In Drug Repurposing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 91: Brazil, Artificial Intelligence In Drug Repurposing Market, Segmentation By Deployment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 92: Middle East, Artificial Intelligence In Drug Repurposing Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 93: Middle East, Artificial Intelligence In Drug Repurposing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 94: Middle East, Artificial Intelligence In Drug Repurposing Market, Segmentation By Deployment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 95: Africa, Artificial Intelligence In Drug Repurposing Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 96: Africa, Artificial Intelligence In Drug Repurposing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 97: Africa, Artificial Intelligence In Drug Repurposing Market, Segmentation By Deployment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 98: Global Artificial Intelligence In Drug Repurposing Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Figure 99: Global Artificial Intelligence In Drug Repurposing Market - Company Scoring Matrix
  • Figure 100: IBM Corporation Financial Performance
  • Figure 101: Evogene Ltd. Financial Performance
  • Figure 102: Ginkgo Bioworks Holdings Inc. Financial Performance
  • Figure 103: BioAge Labs Inc. Financial Performance
  • Figure 104: Insilico Medicine Inc. Financial Performance
  • Figure 105: Global Artificial Intelligence In Drug Repurposing Market, Competitive Benchmarking (In USD Billions)
  • Figure 106: Global Artificial Intelligence In Drug Repurposing Market, Competitive Dashboard
  • Figure 107: Global Artificial Intelligence In Drug Repurposing Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Figure 108: Global, Artificial Intelligence In Drug Repurposing Market Size Gain ($ Billion), Segmentation By Component, 2025 – 2030
  • Figure 109: Global, Artificial Intelligence In Drug Repurposing Market Size Gain ($ Billion), Segmentation By Technology, 2025 – 2030
  • Figure 110: Global, Artificial Intelligence In Drug Repurposing Market Size Gain ($ Billion), Segmentation By Deployment, 2025 – 2030

Top Growth Trends in the Airborne Telemetry Market: Insights into Market Size and Opportunities for 2025-2034

Read More About Top Growth Trends in the Airborne Telemetry Market: Insights into Market Size and Opportunities for 2025-2034

Artificial Intelligence (AI) In Drug Discovery Market Report 2026 - Global Outlook – By Technology (Context-Aware Processing, Natural Language Processing, Deep Learning), By Drug Type (Small Molecules, Large Molecules), ...

Generative Artificial Intelligence (AI) In Drug Discovery Market Report 2026 - Global Outlook – By Type (Small Molecule, Large Molecule), By Technology (Deep Learning, Machine Learning, Reinforcement Learning, Molecular ...

Artificial Intelligence (AI) In Biopharmaceuticals Market Report 2026 - Global Outlook – By Offering (Hardware, Software, Services), By Deployment (Cloud, On-Premises), By Technology (Machine Learning, Natural Language P...

Artificial Intelligence In Medicine Market Report 2026 - Global Outlook – By Type (Hardware, Software, Services), By Technology (Machine Learning, Natural Language Processing, Context-Aware Processing, Computer Vision), ...

Pharmacy Repackaging Systems Market Report 2026 - Global Outlook – By Type (Blister Card Packaging Systems, Pouch Packaging Automation Systems, Liquid Medication Packaging Systems, Bottle Filling Automation Systems), By ...

Lab Automation In Drug Discovery Market Report 2026 - Global Outlook – By Type (Automated Liquid Handlers, Automated Plate Handlers, Robotic Arms, Automated Storage And Retrieval Systems, Other Types), By Component (Inst...

Machine Learning (ML) in The Pharmaceutical Industry Market Report 2026 - Global Outlook – By Component (Solution, Services), By Deployment (Cloud, On-premise), By Enterprise Size (Small and Medium Enterprises (SMEs), La...

Artificial Intelligence (AI) In Predictive Toxicology Market Report 2026 - Global Outlook – By Component (Solution, Services), By Technology (Machine Learning, Other Technologies), By Toxicity Endpoints (Genotoxicity, He...

Frequently Asked Questions

The Artificial Intelligence In Drug Repurposing market was valued at $1.05 billion in 2025, increased to $1.27 billion in 2026, and is projected to reach $2.63 billion by 2030.

The global Artificial Intelligence In Drug Repurposing market is expected to grow at a CAGR of 20.1% from 2026 to 2035 to reach $2.63 billion by 2035.

Some Key Players in the Artificial Intelligence In Drug Repurposing market Include, IBM Corporation, Evogene Ltd., Ginkgo Bioworks Holdings Inc., BioAge Labs Inc., Insilico Medicine Inc., BostonGene Corporation, ISOMORPHIC LABS, Recursion Pharmaceuticals Inc., Deep Genomics Inc., Healx Ltd., Owkin Inc., BullFrog AI Holdings Inc., Aicura Medical GmbH, Kantify, Ignota Labs Ltd., OrphAI Therapeutics, Nabla Bio, Atomwise Inc., BioXcel Therapeutics Inc., Graph AI. .

Major trend in this market includes: Accelerating Treatment Discovery Through Technology Integration. For further insights on this market. request a sample here

North America was the largest region in the artificial intelligence in drug repurposing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial intelligence in drug repurposing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us